Low-dose Aspirin No Longer Recommended to Prevent Cardiovascular Disease

Community NewsPublisher's Picks
568

Translate to Spanish or other 102 languages!

New draft recommendations from the U.S. Preventive Services Task Force recommend against taking aspirin to prevent heart attacks and strokes for most people. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By University of California San Diego Health

New draft recommendations from the U.S. Preventive Services Task Force recommend against taking aspirin to prevent heart attacks and strokes for most people. The Oct. 12, 2021 guidelines are based on new evidence showing that the risks of daily low-dose aspirin — especially from stomach issues and bleeding in the brain due to falls — outweigh the benefits it provides in helping to prevent heart disease for persons 60 years and older.

For people 40 to 59, the task force found only a small net benefit to taking aspirin as a preventive medication.

- Advertisement -

Medical experts say no one currently taking aspirin should quit before consulting their doctor first because the drug still has an anti-inflammatory effect that may provide a net benefit to some patients.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Lactoferrin supplements could aid in the recovery of COVID19 & other Respiratory Tract Infections
Next article
Pioneering Transplant Surgeon Presented with AMA Scientific Achievement Award

More Articles

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.

STHS & Prominence Health Hosting “Senior Living Seminar” on Malnutrition, Sept. 4th

Malnutrition is often an invisible health concern, quietly undermining an older adult's strength, independence and overall quality of life. Yet its warning signs are frequently overlooked or mistaken for a normal part of aging.

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -